Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 32


Smoking cessation and reduction in people with chronic mental illness.

Tidey JW, Miller ME.

BMJ. 2015 Sep 21;351:h4065. doi: 10.1136/bmj.h4065. Review.


Pilot of a Behavioral Activation-Enhanced Smoking Cessation Program for Substance Users With Elevated Depressive Symptoms in Residential Treatment.

Banducci AN, Lejuez CW, MacPherson L.

Addict Newsl Am Psychol Div 50. 2013 Summer;2013:16-20. No abstract available.


Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Leventhal AM, Zvolensky MJ.

Psychol Bull. 2015 Jan;141(1):176-212. doi: 10.1037/bul0000003. Epub 2014 Nov 3.


Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: a growth curve modeling approach.

Minami H, Kahler CW, Bloom EL, Prince MA, Abrantes AM, Strong DR, Niaura R, Miller IW, Palm Reed KM, Price LH, Brown RA.

Exp Clin Psychopharmacol. 2014 Oct;22(5):392-406. doi: 10.1037/a0037156. Epub 2014 Aug 4.


Reward and affective regulation in depression-prone smokers.

Audrain-McGovern J, Wileyto EP, Ashare R, Cuevas J, Strasser AA.

Biol Psychiatry. 2014 Nov 1;76(9):689-97. doi: 10.1016/j.biopsych.2014.04.018. Epub 2014 May 15.


Cognitive deficits specific to depression-prone smokers during abstinence.

Ashare R, Strasser AA, Wileyto EP, Cuevas J, Audrain-McGovern J.

Exp Clin Psychopharmacol. 2014 Aug;22(4):323-31. doi: 10.1037/a0037072. Epub 2014 Jun 16.


Positive Psychotherapy for Smoking Cessation: Treatment Development, Feasibility and Preliminary Results.

Kahler CW, Spillane NS, Day A, Clerkin E, Parks A, Leventhal AM, Brown RA.

J Posit Psychol. 2014 Jan 1;9(1):19-29.


Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.

David SP, Strong DR, Leventhal AM, Lancaster MA, McGeary JE, Munafò MR, Bergen AW, Swan GE, Benowitz NL, Tyndale RF, Conti DV, Brown RA, Lerman C, Niaura R.

Addiction. 2013 Dec;108(12):2202-11. doi: 10.1111/add.12325. Epub 2013 Sep 18.


Anxiety and depressive symptoms and affective patterns of tobacco withdrawal.

Leventhal AM, Ameringer KJ, Osborn E, Zvolensky MJ, Langdon KJ.

Drug Alcohol Depend. 2013 Dec 1;133(2):324-9. doi: 10.1016/j.drugalcdep.2013.06.015. Epub 2013 Jul 26.


Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.

Stapleton J, West R, Hajek P, Wheeler J, Vangeli E, Abdi Z, O'Gara C, McRobbie H, Humphrey K, Ali R, Strang J, Sutherland G.

Addiction. 2013 Dec;108(12):2193-201. doi: 10.1111/add.12304. Epub 2013 Aug 28.


Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.

Bergen AW, Javitz HS, Krasnow R, Nishita D, Michel M, Conti DV, Liu J, Lee W, Edlund CK, Hall S, Kwok PY, Benowitz NL, Baker TB, Tyndale RF, Lerman C, Swan GE.

Pharmacogenet Genomics. 2013 Feb;23(2):94-103. doi: 10.1097/FPC.0b013e32835cdabd.


The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence.

Bergen AW, Javitz HS, Su L, He Y, Conti DV, Benowitz NL, Tyndale RF, Lerman C, Swan GE.

Nicotine Tob Res. 2013 Jul;15(7):1190-200. doi: 10.1093/ntr/nts245. Epub 2012 Dec 3.


Two decades of smoking cessation treatment research on smokers with depression: 1990-2010.

Weinberger AH, Mazure CM, Morlett A, McKee SA.

Nicotine Tob Res. 2013 Jun;15(6):1014-31. doi: 10.1093/ntr/nts213. Epub 2012 Oct 25. Review.


Past major depression and smoking cessation outcome: a systematic review and meta-analysis update.

Hitsman B, Papandonatos GD, McChargue DE, DeMott A, Herrera MJ, Spring B, Borrelli B, Niaura R.

Addiction. 2013 Feb;108(2):294-306. doi: 10.1111/add.12009. Review.


The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population.

Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA.

Addiction. 2012 Oct;107(10):1847-56. doi: 10.1111/j.1360-0443.2012.03889.x. Epub 2012 May 17.


The Relationship between Smoking and Depression Post-Acute Coronary Syndrome.

Busch AM, Borrelli B, Leventhal AM.

Curr Cardiovasc Risk Rep. 2012 Feb 1;5(6):510-518.


Racial/ethnic differences in the longitudinal progression of co-occurring negative affect and cigarette use: from adolescence to young adulthood.

Bares CB, Andrade FH.

Addict Behav. 2012 May;37(5):632-40. doi: 10.1016/j.addbeh.2012.01.016. Epub 2012 Jan 23.


Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders.

Hasin D, Fenton MC, Skodol A, Krueger R, Keyes K, Geier T, Greenstein E, Blanco C, Grant B.

Arch Gen Psychiatry. 2011 Nov;68(11):1158-67. doi: 10.1001/archgenpsychiatry.2011.78.


Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.

Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, O'Connor K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):111-8. doi: 10.1016/j.drugalcdep.2011.03.005. Epub 2011 Apr 19.


Accuracy of a brief screening scale for lifetime major depression in cigarette smokers.

Hitsman B, Buka SL, Veluz-Wilkins AK, Mohr DC, Niaura R, Gilman SE.

Psychol Addict Behav. 2011 Sep;25(3):559-64. doi: 10.1037/a0022772.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk